28010062|t|Covalent Modulators of the Vacuolar ATPase
28010062|a|The vacuolar H(+) ATPase (V-ATPase) is a complex multisubunit machine that regulates important cellular processes through controlling acidity of intracellular compartments in eukaryotes. Existing small-molecule modulators of V-ATPase either are restricted to targeting one membranous subunit of V-ATPase or have poorly understood mechanisms of action. Small molecules with novel and defined mechanisms of inhibition are thus needed to functionally characterize V-ATPase and to fully evaluate the therapeutic relevance of V-ATPase in human diseases. We have discovered electrophilic quinazolines that covalently modify a soluble catalytic subunit of V-ATPase with high potency and exquisite proteomic selectivity as revealed by fluorescence imaging and chemical proteomic activity-based profiling. The site of covalent modification was mapped to a cysteine residue located in a region of V-ATPase subunit A that is thought to regulate the dissociation of V-ATPase. We further demonstrate that a previously reported V-ATPase inhibitor, 3-bromopyruvate, also targets the same cysteine residue and that our electrophilic quinazolines modulate the function of V-ATPase in cells. With their well-defined mechanism of action and high proteomic specificity, the described quinazolines offer a powerful set of chemical probes to investigate the physiological and pathological roles of V-ATPase.
28010062	0	19	Covalent Modulators	T121	C1254351
28010062	27	42	Vacuolar ATPase	T116,T126	C0379099
28010062	47	67	vacuolar H(+) ATPase	T116,T126	C0379099
28010062	69	77	V-ATPase	T116,T126	C0379099
28010062	84	91	complex	T104	C1704241
28010062	105	112	machine	T169	C0449913
28010062	118	127	regulates	T038	C1327622
28010062	138	156	cellular processes	T043	C0007613
28010062	165	176	controlling	T169	C2587213
28010062	177	184	acidity	T081	C0920750
28010062	188	201	intracellular	T082	C0178719
28010062	202	214	compartments	T017	C2349967
28010062	218	228	eukaryotes	T204	C0684063
28010062	239	253	small-molecule	T109	C1328819
28010062	254	264	modulators	T121	C1254351
28010062	268	276	V-ATPase	T116,T126	C0379099
28010062	288	298	restricted	T169	C0443288
28010062	302	311	targeting	T043	C0599894
28010062	316	326	membranous	T080	C0205287
28010062	327	334	subunit	T081	C1711351
28010062	338	346	V-ATPase	T116,T126	C0379099
28010062	362	372	understood	T041	C0162340
28010062	373	383	mechanisms	T169	C0441712
28010062	395	410	Small molecules	T109	C1328819
28010062	416	421	novel	T080	C0205314
28010062	426	433	defined	T080	C0442825
28010062	434	444	mechanisms	T169	C0441712
28010062	448	458	inhibition	T044	C1148560
28010062	468	474	needed	T080	C0027552
28010062	478	490	functionally	T169	C0205245
28010062	491	503	characterize	T052	C1880022
28010062	504	512	V-ATPase	T116,T126	C0379099
28010062	539	550	therapeutic	T169	C0302350
28010062	551	560	relevance	T080	C2347946
28010062	564	572	V-ATPase	T116,T126	C0379099
28010062	576	581	human	T016	C0086418
28010062	582	590	diseases	T047	C0012634
28010062	611	624	electrophilic	T080	C0205556
28010062	625	637	quinazolines	T109	C0034407
28010062	643	660	covalently modify	T044	C3158388
28010062	663	670	soluble	T080	C1948047
28010062	671	688	catalytic subunit	T087	C0600499
28010062	692	700	V-ATPase	T116,T126	C0379099
28010062	706	710	high	T080	C0205250
28010062	711	718	potency	T081	C3854080
28010062	733	754	proteomic selectivity	T080	C0205556
28010062	758	766	revealed	T080	C0443289
28010062	770	790	fluorescence imaging	T060	C0430876
28010062	795	838	chemical proteomic activity-based profiling	T059	C1327760
28010062	844	848	site	T082	C0205145
28010062	861	873	modification	T169	C0392747
28010062	878	884	mapped	T052	C1283195
28010062	890	898	cysteine	T116,T123	C0010654
28010062	899	906	residue	T077	C1709915
28010062	907	917	located in	T082	C0332285
28010062	920	926	region	T087	C1514562
28010062	930	938	V-ATPase	T116,T126	C0379099
28010062	939	948	subunit A	T116	C0599220
28010062	957	964	thought	T041	C0039869
28010062	968	976	regulate	T038	C1327622
28010062	981	993	dissociation	T044	C0301643
28010062	997	1005	V-ATPase	T116,T126	C0379099
28010062	1057	1075	V-ATPase inhibitor	T121	C0014432
28010062	1077	1092	3-bromopyruvate	T109,T130	C0054130
28010062	1099	1106	targets	T169	C1521840
28010062	1111	1115	same	T080	C0445247
28010062	1116	1124	cysteine	T116,T123	C0010654
28010062	1125	1132	residue	T077	C1709915
28010062	1146	1159	electrophilic	T080	C0205556
28010062	1160	1172	quinazolines	T109	C0034407
28010062	1173	1181	modulate	T082	C0443264
28010062	1186	1194	function	T169	C0542341
28010062	1198	1206	V-ATPase	T116,T126	C0379099
28010062	1210	1215	cells	T025	C0007634
28010062	1228	1240	well-defined	T080	C0442825
28010062	1241	1250	mechanism	T169	C0441712
28010062	1254	1260	action	T052	C3266814
28010062	1265	1269	high	T080	C0205250
28010062	1270	1291	proteomic specificity	T081	C0037791
28010062	1307	1319	quinazolines	T109	C0034407
28010062	1328	1336	powerful	T081	C3854080
28010062	1337	1340	set	T077	C1705195
28010062	1344	1359	chemical probes	T120	C2347609
28010062	1363	1374	investigate	T169	C1292732
28010062	1379	1392	physiological	T169	C0205463
28010062	1397	1409	pathological	T169	C1521733
28010062	1410	1415	roles	T077	C1705810
28010062	1419	1427	V-ATPase	T116,T126	C0379099